Efficacy and safety of PD1/PDL1 inhibitors combined with radiotherapy and anti-angiogenic therapy for solid tumors: A systematic review and meta-analysis

The triple combination of programmed cell death 1 (PD1)/programmed cell death ligand 1 (PDL1) inhibitors, radiotherapy (RT), and anti-angiogenesis agents has been widely used in the treatment of solid tumors and has shown positive efficacy. We conducted a meta-analysis to evaluate the efficacy and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Xian, Feng, Wu, Jing, Zhong, Liming, Xu, Guohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997836/
https://www.ncbi.nlm.nih.gov/pubmed/36897735
http://dx.doi.org/10.1097/MD.0000000000033204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997836/
https://www.ncbi.nlm.nih.gov/pubmed/36897735
http://dx.doi.org/10.1097/MD.0000000000033204

Ejemplares similares